Position in ZTS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,876,135
-$838,074 QoQ
Shares Held
81,772
+44.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#312
of 1,408 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $6,186,922 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (95.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
81,772 | $5,876,135 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
1,844 | $310,787 |
All Filings in ZTS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,876,135 | 81,772 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $6,714,209 | 56,799 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $701,320 | 5,574 | Shares | Sole | 2026-04-02 | |
| 2025-09-30 | $3,200,896 | 21,876 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,881,176 | 18,475 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $308,718 | 1,875 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $343,130 | 2,106 | Shares | Sole | 2025-01-29 | |
| 2024-03-31 | $687,669 | 4,064 | Shares | Sole | 2024-05-29 | |
| No filing history on record for this holder in this stock. | ||||||